YHLO_YHLO News

YHLO Successfully Hosts Global Distributors Meeting in Dubai

Time Posted : 2024-02-04

YHLO's National-level Key Project Officially Launched

Time Posted : 2023-12-17

Breaking news! YHLO received FDA 510(k) clearance

Time Posted : 2023-12-13

BSI visited YHLO Shenzhen office, promoting further cooperation

Time Posted : 2023-10-24

Nobel Prize Winner Professor Arieh Warshe visited YHLO

Time Posted : 2023-09-18

Nobel Prize winner in Chemistry, Professor Arieh Warshel visited YHLO, accompanied by the leadership team from The Chinese University of Hong Kong (Shenzhen).

YHLO R&D Center Japan officially settled

Time Posted : 2023-03-17

One more YHLO international regional office!

Time Posted : 2023-03-02

Breaking News!

Time Posted : 2023-02-23

...

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +